About Harman Finochem
Harman Finochem is a company based in Mumbai (India) founded in 1983. The company has 1,772 employees as of April 09, 2024. Harman Finochem offers products and services including Metformin and Fenofibrate.
- Headquarter Mumbai, India
- Employees 1772 as on 09 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Social
Locked
- Legal Name Harman Finochem Limited
- Date of Incorporation 17 Mar, 1983
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$111.69 M (USD)12.54as on Mar 31, 2023
-
Net Profit
$19.17 M (USD)1.87as on Mar 31, 2023
-
EBITDA
$29.93 M (USD)-12.08as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1772
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Harman Finochem
Harman Finochem offers a comprehensive portfolio of products and services, including Metformin and Fenofibrate.
Metformin is manufactured and exported as a key active pharmaceutical ingredient for various formulations.
Fenofibrate is produced and supplied as an active ingredient in pharmaceutical applications.
People of Harman Finochem
Unlock access to complete
Funding Insights of Harman Finochem
Detailed funding history for Harman Finochem
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Harman Finochem
Investment portfolio details for Harman Finochem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Harman Finochem
Detailed financials for Harman Finochem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Harman Finochem Comparisons
Peer comparison for Harman Finochem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Harman Finochem
Detailed competitors of Harman Finochem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Harman Finochem
Complete news archive for Harman Finochem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harman Finochem
Harman Finochem was founded in 1983.
Harman Finochem is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Apr 09, 2024, the latest employee count at Harman Finochem is 1,772.
Annual revenue of Harman Finochem is $111.69M as on Mar 31, 2023.
Harman Finochem Limited is recognized as a key player in the pharmaceutical industry, with active pharmaceutical ingredients being manufactured and exported globally since its establishment in 1983. Core competencies include the production of substances like Metformin and Fenofibrate, supported by world-class facilities and research efforts. Sustainability practices are emphasized, as water recycling and waste reduction initiatives are implemented to achieve targets by 2025 and 2030. Operations are conducted with a focus on quality and environmental responsibility, serving clients worldwide.
Harman Finochem offers Metformin and Fenofibrate.